Medicine guide

BRIVARACETAM VISO FARMACEUTICA

As listed in the register: BRIVARACETAM VISO FARMACEUTICA 50 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG

50 mg · comprimido recubierto con película

  • Prescription only
  • Pain, sleep, mood, epilepsy and the brain
Active substance
Brivaracetam
Made by
Glenmark Arzneimittel Gmbh

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

Medicine groupPain, sleep, mood, epilepsy and the brainN03AX23

Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet

How it works

From the US prescribing label for the same active substance (Briviact). It describes the substance, not this exact product.

The precise mechanism by which BRIVIACT exerts its anticonvulsant activity is not known.

Brivaracetam displays a high and selective affinity for synaptic vesicle protein 2A (SV2A) in the brain, which may contribute to the anticonvulsant effect.

Half-life9 h
Mostly cleared after≈ 45 hfive half-lives — our arithmetic
How the body breaks it down

Brivaracetam is primarily metabolized by hydrolysis of the amide moiety to form the corresponding carboxylic acid metabolite, and secondarily by hydroxylation on the propyl side chain to form the hydroxy metabolite.

How it leaves the body

Brivaracetam is eliminated primarily by metabolism and by excretion in the urine.

With food

The median T max for tablets taken without food is 1 hour (range 0.25 to 3 hours).

Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2026-08-20

Safety of the active substance

From the US prescribing label for the same active substance (Briviact). It describes the substance, not this exact product.

Must not be used by
  • Hypersensitivity to brivaracetam or any of the inactive ingredients in BRIVIACT (bronchospasm and angioedema have occurred) [see Warnings and Precautions (5.4) ].
Most common side effects

Most common adverse reactions are similar to those seen in adult patients.

Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed

Same active substance, strength and form in other countries

Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.

Medicine passport: one printable page to show a pharmacist abroad

European UnionNo exact match for this strength and form

SwitzerlandNo exact match for this strength and form

Details

Made byGlenmark Arzneimittel Gmbh
Active substanceBrivaracetam
Used inPain, sleep, mood, epilepsy and the brain
Strength50 mg
Formcomprimido recubierto con película
ClassificationN03AX23 · Pain, sleep, mood, epilepsy and the brain
Routevía oral
MarketedYes, according to the register
GenericYes — a generic medicine, according to the register
DrivingThe regulator flags that this medicine can affect the ability to drive.
Name in the registerBRIVARACETAM VISO FARMACEUTICA 50 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG
Nº Registro90361

Source: CIMA — Centro de Información online de Medicamentos · 2026-09-30 · not reviewed by a clinician

Fuente: Agencia Española de Medicamentos y Productos Sanitarios (AEMPS), CIMA. Reuse terms: Aviso legal AEMPS.

Other strengths and forms

5 products are sold under this name. Grouped by form; a number on a strength means several companies make it.

Same active substance

These contain the same substance. That does not mean one can replace another — ask a pharmacist.